A Data-Rich Dye

ChromaLIVE™ non-toxic dye goes beyond cell painting to reveal cellular phenotypes in high-content screening

Cell images hold high-density information about cell states and their responses to drugs. However, existing in-vitro assays capture only limited information and offer a simplified view of cell response. Fortunately, with ChromaLIVE, scientists can now reveal much more of the precious information contained in cells.

ChromaLIVE, the leading technology for image-based profiling, generates phenotypic signatures that allow differentiating between drugs or genetic perturbations. It enables scientists to gain better understanding of biological events or drug mechanism at higher throughput than - and with similar biological relevance as - alternative profiling methods like RNA sequencing.

Non-Toxic

Unaffected gene expression patterns and stable in multi-week live cell cultures.

Mix-and-read

One-step, no-wash dye which does not fluoresce in media. Remains in culture media throughout the assay.

Data-rich

ChromaLIVE is a multi-chromatic dye that provides high-density biological information, and therefore helps differentiate subtle phenotypic signatures

ChromaLIVE,  non-toxic, Livecell painting data rich dye for phenotypic profiling. No changes in cellular proliferation.
ChromaLIVE_protocol_schematics.png
identify new MOA, toxic liabilities and off target effects with ChromaLIVE
Abstract_image_DMSO.png

ChromaLIVE™ non-toxic dye now in a new color!

ChromaLIVE™ Deep Red is just like the original ChromaLIVE™ : same biological inertness and same leading technology for drug profiling, but with a different fluorescence spectrum. This means that ChromaLIVE™ Deep Red can be used with NucleoLIVE™ non-toxic nuclear dye to get even more insight from your live cell painting assays. See the ChromaLIVE™ Deep Red protocol and technical note for more information.

Frequently Asked Questions

Interested in our live cell dyes?

Join the 150+ biotech and pharma companies using Saguaro's non-toxic dyes for new insights

Thanks for contacting us. We'll get back to you as soon as possible.

Get in touch with us